Back to entry
Report this entry
Let us know what's wrong. We'll take a look and act if needed.
Beckley and atai leadership unpack Phase 2b results for intranasal 5-MeO-DMT, focusing on adverse events and trial dosing comparisons
psychedelicalpha.com